The FDA has approved EMSAM (selegiline), a transdermal patch, for the treatment of major depression. Selegeline is a MAOI originally used to treat Parkinsons. MAOIs belong to an old class of antidepressants, typically used as a last resort. When taken orally, side effects with these meds tend to be onerous, including risk of tyramine reaction and resulting hypertensive crisis, which necessitates severely restricting ones diet.
The patch was developed by Somerset Pharmaceuticals,...
Read moreDo you ever get the sensation of itching all over your body? I had it so bad last week that I could barely sleep. I kept waking up to... Read more »
On Monday, Novartis, a pharmaceutical giant, received U.S. approval for the Exelon Patch, which delivers a treatment for Alzheimer's... Read more »
Every time I shave my legs, I get itchy, red bumps. How can I get rid of them and how can I prevent them? In order to take care of... Read more »
The FDA has approved Butrans™ (buprenorphine) Transdermal System CIII for the management of moderate to severe chronic pain in patients... Read more »
Frequently I see patients who develop rashes or hives for unclear reasons. Unfortunately when people experience hives on nearly a... Read more »
Results from a late-stage clinical trial show that a new patch is effective for treating shingles pain. Researchers found that the NeurogesX dermal... Read more »
Officials at the U.S. Food and Drug Administration (FDA) are warning patients who wear transdermal (skin patch) medications about problems associated... Read more »
The beginning of summer kicks off the camping and hiking season, anxiously awaited by those who have endured a long cold winter. This year will... Read more »
This is a study to evaluate if the new pain patch ThermoProfen helps relieve pain associated with osteoarthritis of the knee. This national study is... Read more »
Drugmaker Alpharma is reporting that its new Flector pain patch was found safe and effective in new trials. Flector is a... Read more »